Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2017

Jul 28, 2017

34519_dirs_2017-07-28_f83dcf7a-af5c-41c0-8f35-0186babccf08.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2017-07-27

Reporting Person: PESSIN NORMAN H (See Explanation of Responses)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-07-27 Common Stock P 170000 $5.25 Acquired 170000 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 480000 Direct

Footnotes

F1: The Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of common stock. The Reporting Person disclaims beneficial ownership of the shares of common stock reported herein except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Person is the beneficial owner of such shares of common stock for purposes of Section 16 or for any other purpose.

F2: Shares beneficially owned by the Reporting Person's spouse. The Reporting Person expressly disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.